Buying Back into Heidrick & Struggles – Paul Price – Market Shadows

This is a syndicated repost courtesy of MarketShadows. To view original, click here.

Sometimes the best new idea is an old idea.

We sold the shares of executive search firm Heidrick & Struggles (HSII) at $17.37 per share on July 5, 2013. Today we were able to buy back a position at $14.94, a 14% discount to where we sold just twenty-four days ago.

We picked up 250 shares for our Virtual Value Portfolio.  The $3,735 cost came out of our cash reserves. Market Shadows will pocket a quick cash rebate on this purchase as HSII goes ex-dividend for a 13-cent distribution on Wednesday.

HSII   Jul. 29, 2013

At least two private equity firms had been interested in taking HSII private at valuations ranging from $17 – $19 per share. Management says they are committed to staying independent. Experience says that might simply mean they want a higher offer.

Either way it’s likely that HSII is worth well above the sub-$15 we had to pay this morning. The shares have traded way, way higher than that over most of the past decade.

HSII  10-yr. chart (weekly)

Click here to try the Professional Edition for 30 days risk free.

The buyout firms were convinced they could profit from privatizing the company at much higher levels than todays.  Patient investors can pocket almost 4% in yield while waiting for the mean-reversion price that should evolve over the next full business cycle.

Another buyout rumor or an actual takeover would speed up the process.

See full details of all open and closed-out positions here http://marketshadows.com/virtual-portfolios/virtual-portfolio/

Disclosure: Paul Price bought HSII shares in his personal portfolio today as well. My cost ranged from $14.92 – $14.94.

The opinions expressed are those of Market Shadows and the author, not those of the Wall Street Examiner. The Wall Street Examiner provides market commentary content for Market Shadows without compensation at this time but with the expectation of possible future consideration. The Wall Street Examiner does not participate in stock or options selection or strategy recommendations for Market Shadows and makes no representation regarding the accuracy or validity of the ideas expressed in the post. No recommendation or endorsement is intended or implied. This post is presented for informational purposes. Do all necessary due diligence before considering any investment.

Share!Tweet about this on TwitterShare on FacebookShare on LinkedInEmail this to someonePrint this page

Click here to try the Professional Edition for 30 days risk free.